TG6-129

CAS No. 1164464-14-5

TG6-129( TG6 129 | TG6129 )

Catalog No. M27930 CAS No. 1164464-14-5

TG6-129 is an antagonist of the EP2 receptor. TG6-129 suppresses PGE2-induced elevation of cAMP in cells expressing EP2 with an IC50 value of 1.6 μM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 228 Get Quote
10MG 404 Get Quote
25MG 665 Get Quote
50MG 888 Get Quote
100MG 1251 Get Quote
500MG 2538 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    TG6-129
  • Note
    Research use only, not for human use.
  • Brief Description
    TG6-129 is an antagonist of the EP2 receptor. TG6-129 suppresses PGE2-induced elevation of cAMP in cells expressing EP2 with an IC50 value of 1.6 μM.
  • Description
    TG6-129 is an antagonist of the EP2 receptor. TG6-129 suppresses PGE2-induced elevation of cAMP in cells expressing EP2 with an IC50 value of 1.6 μM. TG6-129 reduces the expression of COX-2, IL-1β, IL-6, IL-12, IL-23 and TNF-α induced by the EP2-selective agonist butaprost in P388D1 macrophages.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    TG6 129 | TG6129
  • Pathway
    GPCR/G Protein
  • Target
    Prostaglandin Receptor
  • Recptor
    estrogen receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1164464-14-5
  • Formula Weight
    491.57
  • Molecular Formula
    C20H18FN5O3S3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CCc1nnc(NS(=O)(=O)c2ccc(NC(=S)NC(=O)\C=C\c3ccc(F)cc3)cc2)s1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Guo S, et al. GLL398, an oral selective estrogen receptor degrader (SERD), blocks tumor growth in xenograft breast cancer models. Breast Cancer Res Treat. 2020;180(2):359-368.
molnova catalog
related products
  • 2-Acetylbenzoic acid

    2-Acetylbenzoic acid is more potent than 2-propionyloxybenzoic acid in inhibiting platelet function and platelet prostaglandin (PG) synthesis although the potencies of these agents were comparable in inhibiting prostacyclin (PGI2) synthesis.

  • Desogestrel

    Desogestrel (Org-2969) is a third-generation 19-nortestosterone derivative progestogen and agonist of the progesterone receptor.

  • MK-1029

    ADC-3680 is a potent, selective prostaglandin D2 receptor (DP2, CRTH2) antagonist for the treatment of asthma.